Halozyme Q4 2025 Earnings Surge: Royalty Revenue Soars 52%
Halozyme Therapeutics Inc. (NASDAQ: HALO) hit record revenue. Full-year 2025 revenue reached $1.4 billion. So this is 38% growth year-over-year. ...
Tuesday, September 15, 2026
Tag: Halozyme
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.